Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



Linking Diet and Intestinal Flora with MS

Molecules derived from tryptophan, an amino acid found in turkey and other foods are related to the ability to limit inflammation of the brain. A new study demonstrates for the first time that diet and microbiota influence this inflammation, key in diseases such as multiple sclerosis.

US – New research from Brigham and Women’s Hospital Boston (USA) suggests that bacteria living in the gut are linked in the activity of brain cells involved in the control of inflammation and neurodegeneration.

By using preclinical models and samples from patients with multiple sclerosis, the team found evidence that dietary changes and intestinal flora can influence astrocyte cell, a type of cerebral and consequently neurodegeneration.

These results, published yesterday in the journal Nature Medicine, may be useful in the development of possible therapeutic targets for diseases related to inflammatory processes, such as multiple sclerosis.

Francisco Quintana, Spanish researcher who led the work, told SINC: “we have demonstrated for the first time that diet and intestinal bacteria collaborate to produce metabolites that travel through the circulation to the central nervous system to regulate inflammation and neurodegeneration.”

Or put another way, the food has some sort of role in the central nervous system through inflammation.  “What we eat influences the ability of intestinal bacteria to produce small molecules, some of which are able to travel to the brain. This opens an unknown area so far. How the intestine controls inflammation of the brain,” he added.

According to the authors, dietary supplements and probiotics may be useful to control processes that contribute to the pathology of neurological diseases. “Our studies were initially focused on multiple sclerosis, but also have implications for other diseases such as Alzheimer’s and Parkinson’s,” said Quintana.

Turkey to limit brain inflammation
Previous research had suggested a link between the intestinal microbiome and inflammation of the brain, but until now was not known how they are related and how diet and microbial products influence this.

To explore this connection, Quintana and colleagues performed transcriptional expression analysis of astrocytes in a mouse model of multiple sclerosis, by identifying a molecular pathway involved in inflammation.

Thus, they found that molecules derived from tryptophan (an amino acid found in turkey and other foods) act on this pathway, and that when these molecules are more present, the astrocytes are able to limit brain inflammation.

In fact, the team found low levels of these tryptophan molecules in blood samples from patients with multiple sclerosis. “Deficits in the intestinal flora, dietary or absorption capacity transport or bowel can lead to deficiencies that contribute to the progression of the disease,” said Quintana.

Story Source: The above story is based on materials provided by SCIENCENEWSHUB
Note: Materials may be edited for content and length


Go to Newer News Go to Older News